The roots of cancer: Stem cells and the basis for tumor heterogeneity

BioEssays

Volumn 35, Issue 3, 2013, Pages 253-260

  Shibata, Maho ^a   Shen, Michael M ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Cancer stem cell; Cell of mutation; Cell of origin; Clonal evolution; Tumor initiating cell

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL RENEWAL; CELL TRANSFORMATION; CLONAL EVOLUTION; EPITHELIUM BASAL CELL; GENETIC MANIPULATION; HUMAN; MALIGNANT TRANSFORMATION; NEURAL STEM CELL; NONHUMAN; ONCOGENE; PROSTATE CANCER; SIGNAL TRANSDUCTION; STEM CELL RESEARCH; TUMOR SUPPRESSOR GENE;

ANIMALS; CLONE CELLS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84873566048     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201200101     Document Type: Article

References (45)

1. Visvader JE. 2011. Cells of origin in cancer. Nature 469: 314-22.
2. Liu C, Sage JC, Miller MR, Verhaak RG, et al. 2011. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146: 209-21.
3. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, et al. 2009. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15: 45-56.
4. Wang Y, Yang J, Zheng H, Tomasek GJ, et al. 2009. Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 15: 514-26.
5. Zhu Y, Guignard F, Zhao D, Liu L, et al. 2005. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8: 119-30.
6. Wang X, Kruithof-de Julio M, Economides KD, Walker D, et al. 2009. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461: 495-500.
7. Goldstein AS, Drake JM, Burnes DL, Finley DS, et al. 2011. Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc 6: 656-67.
8. Goldstein AS, Huang J, Guo C, Garraway IP, et al. 2010. Identification of a cell of origin for human prostate cancer. Science 329: 568-71.
9. Lawson DA, Zong Y, Memarzadeh S, Xin L, et al. 2010. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 107: 2610-5.
10. Taylor RA, Toivanen R, Frydenberg M, Pedersen J, et al. 2012. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Stem Cells 30: 1087-96.
11. Choi N, Zhang B, Zhang L, Ittmann M, et al. 2012. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 21: 253-65.
12. Liu J, Pascal LE, Isharwal S, Metzger D, et al. 2011. Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol Endocrinol 25: 1849-57.
13. Zhang L, Zhang B, Han SJ, Shore AN, et al. 2012. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis. Transgenic Res 21: 1117-23.
14. Risbridger GP, Wang H, Frydenberg M, Cunha G. 2001. The metaplastic effects of estrogen on mouse prostate epithelium: proliferation of cells with basal cell phenotype. Endocrinology 142: 2443-50.
15. Martin NE, Mucci LA, Loda M, Depinho RA. 2011. Prognostic determinants in prostate cancer. Cancer J 17: 429-37.
16. Sboner A, Demichelis F, Calza S, Pawitan Y, et al. 2010. Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 3: 8.
17. Visvader JE. 2009. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 23: 2563-77.
18. Molyneux G, Geyer FC, Magnay FA, McCarthy A, et al. 2010. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7: 403-17.
19. Lim E, Vaillant F, Wu D, Forrest NC, et al. 2009. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-13.
20. Van Keymeulen A, Rocha AS, Ousset M, Beck B, et al. 2011. Distinct stem cells contribute to mammary gland development and maintenance. Nature 479: 189-93.
21. Clarke MF, Fuller M. 2006. Stem cells and cancer: two faces of Eve. Cell 124: 1111-5.
22. Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-11.
23. Magee JA, Piskounova E, Morrison SJ. 2012. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21: 283-96.
24. Clarke MF, Dick JE, Dirks PB, Eaves CJ, et al. 2006. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-44.
25. Rosen JM, Jordan CT. 2009. The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-3.
26. Shackleton M, Quintana E, Fearon ER, Morrison SJ. 2009. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822-9.
27. + stem cell activity in mouse intestinal adenomas. Science 337: 730-5.
28. Driessens G, Beck B, Caauwe A, Simons BD, et al. 2012. Defining the mode of tumour growth by clonal analysis. Nature 488: 527-30.
29. Chen J, Li Y, Yu TS, McKay RM, et al. 2012. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488: 522-6.
30. - metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-20.
31. Quintana E, Shackleton M, Foster HR, Fullen DR, et al. 2010. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18: 510-23.
32. Quintana E, Shackleton M, Sabel MS, Fullen DR, et al. 2008. Efficient tumour formation by single human melanoma cells. Nature 456: 593-8.
33. Ishizawa K, Rasheed ZA, Karisch R, Wang Q, et al. 2010. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 7: 279-82.
34. + cell population is enriched in tumor-initiating cells. Cancer Res 67: 6796-805.
35. Rajasekhar VK, Studer L, Gerald W, Socci ND, et al. 2011. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2: 162.
36. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, et al. 1999. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-11.
37. Toivanen R, Berman DM, Wang H, Pedersen J, et al. 2011. Brief report: a bioassay to identify primary human prostate cancer repopulating cells. Stem Cells 29: 1310-4.
38. Collins AT, Habib FK, Maitland NJ, Neal DE. 2001. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114: 3865-72.
39. high stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69: 8555-62.
40. Greaves M, Maley CC. 2012. Clonal evolution in cancer. Nature 481: 306-13.
41. Notta F, Mullighan CG, Wang JC, Poeppl A, et al. 2011. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469: 362-7.
42. Anderson K, Lutz C, van Delft FW, Bateman CM, et al. 2011. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469: 356-61.
43. Qin J, Liu X, Laffin B, Chen X, et al. 2012. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10: 556-69.
44. Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, et al. 2011. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9: 357-65.
45. Gupta PB, Fillmore CM, Jiang G, Shapira SD, et al. 2011. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146: 633-44.